Connect your AI

Medline, Inc. MDLN Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

McKessonMCK

——

Henry ScheinHSIC

——

UFP TechnologiesUFPT

——

ICU MedicalICUI

——

IAR

Integra LifeSciencesIART

——

CorMedixCRMD

——

Other financials

Income statement

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medline, Inc. 's preferred stock, par or stated value per share?: Medline, Inc. (MDLN) reported preferred stock, par or stated value per share of $0 in Q1 2026.